Columbia Care Inc
F:3LP
Relative Value
There is not enough data to reliably calculate the relative value of 3LP.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
3LP Competitors Multiples
Columbia Care Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Columbia Care Inc
F:3LP
|
126.7m EUR | 0.3 | -0.4 | 17.1 | -9.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
567.6B USD | 6 | 21.2 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.1B GBP | 4.9 | 28.4 | 15.8 | 22.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
224.2B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
281.2B USD | 4.3 | 15.4 | 9.6 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.4B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.4B USD | 2.4 | 16.3 | 6.9 | 8.6 |